M. Millward

机构：Linear Clinical Research

发表论文 4 篇 · 总被引 82 次 · h-index 3

代表论文

• Dabrafenib plus trametinib versus dabrafenib monotherapy in patients with metastatic BRAF V600E/K-mutant melanoma: long-term survival and safety analysis of a phase 3 study (2019 · Annals of Oncology · 被引 67)
• 916O Preliminary phase I results of INCB161734, a novel oral KRAS G12D inhibitor, in patients with advanced or metastatic solid tumors (2025 · Annals of Oncology · 被引 10)
• 691TiP PYNNACLE phase II trial of rezatapopt (PC14586) in solid tumors with a TP53 Y220C mutation (2024 · Annals of Oncology · 被引 4)
• 500LBA LBA Orals: Preliminary safety and anti-tumor activity of TYRA-300, a highly selective FGFR3 inhibitor, in participants with advanced solid tumors with activating FGFR3 mutations/fusions (SURF301) (2024 · European Journal of Cancer · 被引 1)